← Back to Search

Behavioral Intervention

Lifestyle Changes for Atrial Fibrillation

N/A
Waitlist Available
Led By Amanda Bonikowske
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Paroxysmal or persistent atrial fibrillation.
Be older than 18 years old
Must not have
Prior catheter ablation.
Longstanding persistent AF.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at how lifestyle changes and rehab may improve AF symptoms before ablation surgery.

Who is the study for?
This trial is for individuals with occasional or ongoing atrial fibrillation who are scheduled for a catheter ablation procedure. It's not suitable for those who've had this procedure before, have a pacemaker/ICD, suffer from long-term persistent AF, or have uncontrolled AF needing urgent treatment.
What is being tested?
The study is testing the effects of a comprehensive lifestyle program on symptoms related to Atrial Fibrillation. This includes cardiac rehabilitation and aims to improve patient outcomes prior to undergoing catheter ablation.
What are the potential side effects?
Since this intervention involves lifestyle changes and cardiac rehab rather than medication, side effects may include muscle soreness from exercise and potential stress from dietary adjustments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have irregular heartbeats that come and go or stay.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had a catheter ablation procedure before.
Select...
I have had atrial fibrillation for a long time.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Cardiac Rehab Sessions Attended
Secondary study objectives
Change in Atrial Fibrillation (AF) Symptom severity
Change in exercise capacity
Change in weight loss
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Lifestyle Interventions Pre-ProcedureExperimental Treatment1 Intervention
Subjects with paroxysmal or persistent atrial fibrillation (AF) who are scheduled to undergo elective catheter ablation of AF will participate in a 12-week multicomponent lifestyle intervention program.
Group II: Standard of CareActive Control1 Intervention
Subjects who have previously undergone catheter ablation of atrial fibrillation (AF) as part of their standard of care will have medical chart review completed to gather information.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,341 Previous Clinical Trials
3,062,192 Total Patients Enrolled
32 Trials studying Atrial Fibrillation
13,548 Patients Enrolled for Atrial Fibrillation
Amanda BonikowskePrincipal InvestigatorMayo Clinic
~27 spots leftby Aug 2025